Madayag, R M <br/><br/>
Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.  [electronic resource] 

 -  Transplantation  Dec 1997 
 - 1781-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199712270-00027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cadaver<br/>Female<br/>Hepatitis B--transmission<br/>Hepatitis B Antibodies--immunology<br/>Hepatitis B Core Antigens--immunology<br/>Humans<br/>Kidney Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Risk<br/>Tissue Donors